Zinc chelated to citrate. Bioavailability comparable to zinc gluconate (~20–25%); preferred form in some lozenge formulations for upper respiratory infections. ~31% elemental Zn by weight.
Half-Life & Elimination Curve (PO: 4h)
Plasma (PO)t½ Decay (4h)
0×t½0h100%(46 µg/L)
1×t½4h50%(23 µg/L)
2×t½8h25%(11.5 µg/L)
3×t½12h12.5%(5.76 µg/L)
4×t½16h6.3%(2.88 µg/L)
5×t½20h3.1%(1.44 µg/L)
Elimination t½4h (PO)
Rate Constant (ke)0.173 h⁻¹
Time to Peak (Tmax)2.91h
Est. Peak (Cmax)46 µg/L
Clearance (CL)34.7 L/h
97% Washout (5×t½)20h
Dosing Guidelines
Oral (PO): Typical 25 mg (Range: 15–50 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 61% · Volume of Distribution (Vd): 200 L · Absorption (ka): 0.6 h⁻¹ (t½ka ≈ 1.16h) [PMID 24259556]